ASX - By Stock
|
92E Notices |
Re:
New Investors Information 92E
|
|
bread89
|
367 |
256K |
1 |
24/09/21 |
24/09/21 |
ASX - By Stock
|
367
|
256K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
??
|
|
bread89
|
50 |
9.7K |
4 |
14/08/21 |
14/08/21 |
ASX - By Stock
|
50
|
9.7K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
??
|
|
bread89
|
50 |
9.7K |
2 |
14/08/21 |
14/08/21 |
ASX - By Stock
|
50
|
9.7K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Quarterly Activity Report
|
|
bread89
|
105 |
23K |
0 |
04/08/21 |
04/08/21 |
ASX - By Stock
|
105
|
23K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Covid-19 Rapid testing kits
|
|
bread89
|
30 |
6.2K |
1 |
02/08/21 |
02/08/21 |
ASX - By Stock
|
30
|
6.2K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Covid-19 Rapid testing kits
|
|
bread89
|
30 |
6.2K |
4 |
01/08/21 |
01/08/21 |
ASX - By Stock
|
30
|
6.2K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Quarterly Activity Report
|
|
bread89
|
105 |
23K |
1 |
20/07/21 |
20/07/21 |
ASX - By Stock
|
105
|
23K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Reports Record QVC Sales
|
|
bread89
|
111 |
24K |
0 |
13/07/21 |
13/07/21 |
ASX - By Stock
|
111
|
24K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Reports Record QVC Sales
|
|
bread89
|
111 |
24K |
1 |
03/07/21 |
03/07/21 |
ASX - By Stock
|
111
|
24K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: FGF5 Inhibitors Supply Agreement - Additional Information
|
|
bread89
|
35 |
9.4K |
4 |
12/06/21 |
12/06/21 |
ASX - By Stock
|
35
|
9.4K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
An Evaluation of CDY Going Forward
|
|
bread89
|
120 |
26K |
3 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
120
|
26K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Agreement Signed for Sale of Lyramid Limited
|
|
bread89
|
333 |
54K |
1 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
333
|
54K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Midkine and COVID 19
|
|
bread89
|
72 |
13K |
0 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
72
|
13K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Midkine and COVID 19
|
|
bread89
|
72 |
13K |
1 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
72
|
13K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Rights Issue
|
|
bread89
|
112 |
23K |
0 |
13/03/21 |
13/03/21 |
ASX - By Stock
|
112
|
23K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Rights Issue
|
|
bread89
|
112 |
23K |
0 |
13/03/21 |
13/03/21 |
ASX - By Stock
|
112
|
23K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Receives First Order From Chinese Distributor
|
|
bread89
|
50 |
12K |
1 |
12/03/21 |
12/03/21 |
ASX - By Stock
|
50
|
12K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Receives First Order From Chinese Distributor
|
|
bread89
|
50 |
12K |
0 |
12/03/21 |
12/03/21 |
ASX - By Stock
|
50
|
12K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Newsletter
|
|
bread89
|
18 |
4.4K |
1 |
28/12/20 |
28/12/20 |
ASX - By Stock
|
18
|
4.4K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change of Director's Interest Notice - Eck
|
|
bread89
|
5 |
1.2K |
3 |
24/12/20 |
24/12/20 |
ASX - By Stock
|
5
|
1.2K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Growth Strategy Presentation
|
|
bread89
|
58 |
11K |
0 |
27/11/20 |
27/11/20 |
ASX - By Stock
|
58
|
11K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Growth Strategy Presentation
|
|
bread89
|
58 |
11K |
0 |
14/11/20 |
14/11/20 |
ASX - By Stock
|
58
|
11K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Is this it?
|
|
bread89
|
104 |
35K |
0 |
14/11/20 |
14/11/20 |
ASX - By Stock
|
104
|
35K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appointment of Dr Dominic Burg as Chief Operating Officer
|
|
bread89
|
38 |
11K |
1 |
03/11/20 |
03/11/20 |
ASX - By Stock
|
38
|
11K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: CDY Signs Agreement With Premium Salon Distributor in USA
|
|
bread89
|
33 |
9.2K |
2 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
33
|
9.2K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
10 things I love about Avita Medical
|
|
bread89
|
11 |
11K |
9 |
19/02/20 |
19/02/20 |
ASX - By Stock
|
11
|
11K
|
9
|
|
ASX - By Stock
|
AVH |
Re:
AVH charting perspective
|
|
bread89
|
479 |
3.0M |
3 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
479
|
3.0M
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
market re-rate
|
|
bread89
|
422 |
177K |
2 |
18/02/20 |
18/02/20 |
ASX - By Stock
|
422
|
177K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Broker analysis
|
|
bread89
|
109 |
94K |
10 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
109
|
94K
|
10
|
|
ASX - By Stock
|
AVH |
Re:
Broker analysis
|
|
bread89
|
109 |
94K |
0 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
109
|
94K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Broker analysis
|
|
bread89
|
109 |
94K |
0 |
07/02/20 |
07/02/20 |
ASX - By Stock
|
109
|
94K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Broker analysis
|
|
bread89
|
109 |
94K |
6 |
07/02/20 |
07/02/20 |
ASX - By Stock
|
109
|
94K
|
6
|
|
ASX - By Stock
|
AVH |
Re:
Broker analysis
|
|
bread89
|
109 |
94K |
5 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
109
|
94K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid's Evolis Patent to be Granted in China
|
|
bread89
|
40 |
18K |
4 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
40
|
18K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
market re-rate
|
|
bread89
|
422 |
177K |
3 |
22/01/20 |
22/01/20 |
ASX - By Stock
|
422
|
177K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
market re-rate
|
|
bread89
|
422 |
177K |
0 |
21/01/20 |
21/01/20 |
ASX - By Stock
|
422
|
177K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
market re-rate
|
|
bread89
|
422 |
177K |
0 |
21/01/20 |
21/01/20 |
ASX - By Stock
|
422
|
177K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
More News-Worthy Recell Goodness
|
|
bread89
|
305 |
259K |
0 |
19/01/20 |
19/01/20 |
ASX - By Stock
|
305
|
259K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
More News-Worthy Recell Goodness
|
|
bread89
|
305 |
259K |
0 |
15/01/20 |
15/01/20 |
ASX - By Stock
|
305
|
259K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Shareholders
|
|
bread89
|
5 |
4.6K |
0 |
14/01/20 |
14/01/20 |
ASX - By Stock
|
5
|
4.6K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
More News-Worthy Recell Goodness
|
|
bread89
|
305 |
259K |
1 |
11/01/20 |
11/01/20 |
ASX - By Stock
|
305
|
259K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Receives FDA IDE Approval to Evaluate RECELL for Vitil
|
|
bread89
|
35 |
23K |
0 |
01/01/20 |
01/01/20 |
ASX - By Stock
|
35
|
23K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Trading Halt
|
|
bread89
|
42 |
26K |
3 |
11/11/19 |
11/11/19 |
ASX - By Stock
|
42
|
26K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Notes to Appendix 4C
|
|
bread89
|
30 |
10K |
1 |
24/10/19 |
24/10/19 |
ASX - By Stock
|
30
|
10K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Q3 2019 Revenue Expectations
|
|
bread89
|
7 |
6.8K |
6 |
19/10/19 |
19/10/19 |
ASX - By Stock
|
7
|
6.8K
|
6
|
|
ASX - By Stock
|
AVH |
Re:
This show..very nice
|
|
bread89
|
44 |
28K |
2 |
15/10/19 |
15/10/19 |
ASX - By Stock
|
44
|
28K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Announces Listing on Nasdaq
|
|
bread89
|
53 |
30K |
2 |
03/10/19 |
03/10/19 |
ASX - By Stock
|
53
|
30K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 3B
|
|
bread89
|
13 |
3.5K |
5 |
31/07/19 |
31/07/19 |
ASX - By Stock
|
13
|
3.5K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Notes to Appendix 4C
|
|
bread89
|
32 |
11K |
2 |
30/07/19 |
30/07/19 |
ASX - By Stock
|
32
|
11K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C and Notes to Appendix 4C
|
|
bread89
|
32 |
11K |
0 |
29/07/19 |
29/07/19 |
ASX - By Stock
|
32
|
11K
|
0
|
|